BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6785940)

  • 1. [Clinical significance of peptide hormones LH, FSH, TSH, prolactin, HCG, parathormone, calcitonin and prostaglandin F2 alpha in kidney neoplasms].
    Dunzendorfer U; Drahovsky D; Schmidt-Gayk H; Zahradnik HP
    Z Urol Nephrol; 1981 Jan; 74(1):13-9. PubMed ID: 6785940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peptide hormones LH, FSH, TSH, prolactin, beta-HCG and PTH in patients with urogenital tumors].
    Dunzendorfer U; Drahovsky D; Schmidt-Gayk H
    Onkologie; 1981 Aug; 4(4):188-92. PubMed ID: 6795555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LH, FSH, TSH, prolactin, HCG and prostaglandin F2 alpha in patients with treated testis tumors.
    Dunzendorfer U; Drahovksy D; Zahradnik HP
    Andrologia; 1980; 12(6):504-9. PubMed ID: 6781377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide hormones in liver cirrhosis and hepatocellular carcinoma.
    Scheuer A; Grün R; Lehmann FG
    Oncodev Biol Med; 1981; 2(1-2):1-10. PubMed ID: 6272236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cloprostenol and prostaglandin F2 alpha on secretion of follicle stimulating hormone, luteinizing hormone, prolactin, growth hormone, thyroxine and cortisol in heifers.
    Furr BJ; Cooper MJ; Jackson PS; Hart IC; Pope GS
    Acta Vet Scand Suppl; 1981; 77():55-69. PubMed ID: 6795907
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats.
    Lafuente A; Alvarez-Demanuel E; Blanco A; García-Bonacho M; Esquifino AI
    Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between exogenous luteinizing hormone (hCG), prolactin and prostaglandin F2 alpha on serum enzymes in the rat.
    Salib AA; Farahat AA; Younis M; Makhla AM
    Acta Physiol Hung; 1986; 68(1):33-7. PubMed ID: 3463121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered polyamines and peptide hormones (FSH, TSH, prolactin, C-peptide) in prostatic hyperplasia and kidney tumors.
    Dunzendorfer U; Russell DH
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(4):301-5. PubMed ID: 91441
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating LH, FSH, T, prolactin, TSH, T3, T4, GH and insulin in pubertal females.
    Bughi S; Carabulea G; Eşanu C; Klepsch I
    Endocrinologie; 1980; 18(1):47-52. PubMed ID: 6987726
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothalamic-pituitary gonadal axis and immune response imbalance during chronic filarial infections.
    Mavoungou D; Poaty-Mavoungou V; Ongali B; Akoume MY; Maka G; Mavoungou E
    Trop Med Int Health; 2005 Nov; 10(11):1180-6. PubMed ID: 16262744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone studies in health and disease using radioimmunological assay.
    Greenwood FC; Landon J
    Prog At Med; 1968; 2():1-38. PubMed ID: 4947474
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogens in carcinoma of the prostate. Effects on enzymes and polypeptide hormones.
    Dunzendorfer U; Drahovsky D
    Arzneimittelforschung; 1978; 28(6):1027-30. PubMed ID: 86358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].
    Brailly-Tabard S; Trabado S; Khallouf O
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S329-33. PubMed ID: 19268210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone profile in lepromatous leprosy. A preliminary study.
    Rolston R; Mathews M; Taylor PM; Koshy TS
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):31-6. PubMed ID: 6788722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin, LH, TSH, T3 and T4 in patients with urogenital carcinomas.
    Dunzendorfer U; Knöner M; Drahowsky D
    Urol Int; 1979; 34(3):190-8. PubMed ID: 573007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers and endocrinologic aspects in intracranial germinoma].
    Andler W; Horstmann W; Distelmeier PM
    Klin Padiatr; 1985; 197(1):58-60. PubMed ID: 2579260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormones in renal cancer.
    Sufrin G; Mirand EA; Moore RH; Chu TM; Murphy GP
    Trans Am Assoc Genitourin Surg; 1976; 68():115-20. PubMed ID: 1030544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical examination and endocrinologic diagnosis of male infertility (author's transl)].
    Hetzel WD
    MMW Munch Med Wochenschr; 1981 May; 123(20):829-32. PubMed ID: 6792510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
    Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
    Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.